Inducible nitric oxide synthase blockade with aminoguanidine, protects mice infected with Nocardia brasiliensis from actinomycetoma development

• Published in: PLoS neglected tropical diseases 2020-10, Vol.14 (10), p.e0008775-e0008775
• Main Authors: Salinas-Carmona, Mario C, Longoria-Lozano, Ossian, Garza-Esquivel, Humberto R, López-Ulloa, Juan, Reyes-Carrillo, Jorge, Vázquez-Marmolejo, Anna Velia
• Format: Article
• Language: English
• Subjects: Abscesses; Actinomycetales infections; Adaptive immunity; Aminoguanidine; Amputation; Animal models; Animals; Antibodies; Arginine; Bacteria; Bacterial infections; Biology and Life Sciences; Cell proliferation; Cells; Chemical properties; Colonies; Cytokines; Disease Progression; Drug therapy; Endothelial cells; Enzyme inhibitors; Etiology; Female; Fistulae; Free radicals; Fungi; Gene expression; Granuloma; Granulomas; Guanidines - administration & dosage; Health aspects; Humans; Immunity; Infections; Infectious diseases; Inflammation; Intracellular killing; Investigations; Leukocytes (neutrophilic); Lymphocytes; Lymphocytes T; Macrophages; Macrophages - immunology; Maduromycosis; Medical treatment; Medicine and Health Sciences; Mice; Mice, Inbred BALB C; Mycetoma - drug therapy; Mycetoma - enzymology; Mycetoma - immunology; Mycetoma - microbiology; Neutrophils - immunology; Nitric oxide; Nitric Oxide - immunology; Nitric Oxide Synthase Type II - antagonists & inhibitors; Nitric Oxide Synthase Type II - genetics; Nitric Oxide Synthase Type II - immunology; Nitric-oxide synthase; Nocardia; Nocardia - drug effects; Nocardia - physiology; Oxidoreductases; Pathogenesis; Pathogens; Proliferation; Protected animals; Sinuses; Supervision; Tissue; Tissues; Tropical diseases; Tuberculosis
• ISSN: 1935-2735; 1935-2727; 1935-2735
• DOI: 10.1371/journal.pntd.0008775

Mycetoma is a chronic infectious disease that can be caused by fungi or bacteria, Madurella mycetomatis and Nocardia brasiliensis are frequent etiologic agents of this disease. Mycetoma produced by bacteria is known as actinomycetoma. In mycetoma produced by fungi (eumycetoma) and actinomycetoma, diagnosis of the disease is based on clinical findings: severe inflammation, with deformities of affected tissues, abscesses, fistulae, sinuses and discharge of purulent material that contains micro colonies of the etiologic agent. Microscopic examination of infected tissue is similar regardless of the offending microbe; hallmark of infected tissue is severe inflammation with abundant neutrophils around micro colonies and granuloma formation with macrophages, lymphocytes, dendritic and foamy cells. Even though medical treatment is available for mycetoma patients, amputation, or surgical intervention is frequently needed. The pathogenesis of actinomycetoma is little known, most information was obtained from experimental animal models infected with bacteria. In other experimental mice infections with different microbes, it was demonstrated that nitric oxide is responsible for the intracellular killing of Mycobacterium tuberculosis by activated macrophages. Nitric oxide is a free radical with potent stimulatory and suppressive effects in innate and adaptive immunity. The unstable nitric oxide molecule is produced by action of nitric oxide synthases on L-arginine. There are three nitric oxide synthases expressed in different cells and tissues, two are constitutively expressed one in neurons, and the other in endothelial cells and one that is inducible in macrophages. Aminoguanidine is a competitive inhibitor of inducible nitric oxide synthase. Its administration in experimental animals may favor or harm them. We used aminoguanidine in mice infected with Nocardia brasiliensis, and demonstrated that all treated animals were protected from actinomycetoma development. Anti N. brasiliensis antibodies and T cell proliferation were not affected, but inflammation was reduced.